(Q33518314)

English

Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

1 reference

Europe PubMed Central

Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

bipolar I disorder

1 reference

based on heuristic

inferred from title

schizoaffective disorder

1 reference

based on heuristic

inferred from title

1

object named as

John M Kane

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Christoph Correll

3

object named as

Christoph U Correll

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

4

object named as

Gary Sachs

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

Thomas R E Barnes

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Peter Buckley

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

James Eudicone

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Robert McQuade

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Quynh-Van Tran

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Andrei Pikalov

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sheila Assunção-Talbott

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

14 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1019-1029

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

The Barnes Akathisia Rating Scale--revisited

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Akathisia: a comprehensive review and treatment summary

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

The incidence of akathisia in bipolar affective disorder treated with neuroleptics--a preliminary report

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Diagnosis and management of acute movement disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Atypicality of atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

The Hillside Akathisia Scale: a reliability comparison of the English and German versions

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Atypical antipsychotics have very different adverse effect profiles and should not be lumped together.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Modern antipsychotic drugs: a critical overview

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Extrapyramidal side effects with atypical neuroleptics in bipolar disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Fluoxetine dose-increment related akathisia in depression: implications for clinical care, recognition and management of selective serotonin reuptake inhibitor-induced akathisia

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Extrapyramidal side effects are unacceptable

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Dopamine partial agonists: a new class of antipsychotic

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Lessons from each drug trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Aripiprazole: pharmacology and evidence in bipolar disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Tardive Dystonia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Cyproheptadine treatment in neuroleptic-induced akathisia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

A rating scale for acute drug-induced akathisia: development, reliability, and validity

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348157

21 January 2018

Identifiers

10.1177/0269881109348157

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33518314&oldid=1768967117"